by Journal for ImmunoTherapy of Cancer
Chimeric antigen receptor (CAR) T-cell therapy has not achieved the same level of success with solid tumors as it has with hematological cancers, but results of a preclinical experiment suggest...
by Diabetes Technology & Therapuetics
Designing chimeric antigen receptor (CAR) T regulatory cells (Tregs) to detect glutamic acid decarboxylase, 65 kD isoform (GAD65) has the potential to reverse type 1 diabetes (T1D) in adults,...
by Blood
Phase III study results support Orca-T immunotherapy as a novel intervention and less toxic alternative to traditional tacrolimus and methotrexate (Tac/MTX) for GVHD prophylaxis following...
by Bone Marrow Transplantation
Results of a systematic review and meta-analysis affirm eltrombopag as a viable intervention against thrombocytopenia, a complication of allogeneic hematopoietic cell transplantation (allo-HCT).
by ASTCT Advocacy Update
Congress Makes Progress on FY 2026 Funding; Turns Attention to Mid-Term Elections
by ASTCT
The following infographics are based on ASTCT's December 2, 2026 webinar in which Dr. Michael D. Jain (Moffitt Cancer Center) and Dr. Stephen Gottschalk (St. Jude Children’s...